Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc
Publication
, Conference
Heimall, J; Logan, BR; Cowan, MJ; Notarangelo, LD; Puck, J; Fleisher, T; Griffith, LM; Kohn, DB; Pulsipher, MA; Shearer, W; Hanson, IC ...
Published in: Biology of Blood and Marrow Transplantation
March 2016
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
March 2016
Volume
22
Issue
3
Start / End Page
S101 / S102
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Heimall, J., Logan, B. R., Cowan, M. J., Notarangelo, L. D., Puck, J., Fleisher, T., … Buckley, R. H. (2016). Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc. In Biology of Blood and Marrow Transplantation (Vol. 22, pp. S101–S102). Elsevier BV. https://doi.org/10.1016/j.bbmt.2015.11.404
Heimall, Jennifer, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Jennifer Puck, Thomas Fleisher, Linda M. Griffith, et al. “Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc.” In Biology of Blood and Marrow Transplantation, 22:S101–2. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.404.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Puck J, Fleisher T, et al. Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2016. p. S101–2.
Heimall, Jennifer, et al. “Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc.” Biology of Blood and Marrow Transplantation, vol. 22, no. 3, Elsevier BV, 2016, pp. S101–02. Crossref, doi:10.1016/j.bbmt.2015.11.404.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Puck J, Fleisher T, Griffith LM, Kohn DB, Pulsipher MA, Shearer W, Hanson IC, Kapoor N, O’Reilly RJ, Boyer M, Pai S-Y, Parikh S, Goldman F, Burroughs L, Marsh RA, Kletzel M, Thakar M, Connelly JA, Cuvellier G, Loechelt B, Shereck E, Knudsen A, Sullivan K, DeSantes K, Gillio AP, Haddad E, Petrovic A, Quigg TC, Smith AR, Stenger E, Dvorak CC, Buckley RH. Poor T Cell Reconstitution at 100 Days after T Cell-Replete Hematopoietic Cell Transplantation (HCT) for SCID Is Associated with Later Risk of Death or Need for 2nd Transplant in the 6901 Prospective Study of the Pidtc. Biology of Blood and Marrow Transplantation. Elsevier BV; 2016. p. S101–S102.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
March 2016
Volume
22
Issue
3
Start / End Page
S101 / S102
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences